bioRxivPharmacology & ToxicologyPreprint
Lung infection by P. aeruginosa induces neuroinflammation and blood-brain barrier dysfunction in mice
N. Villalba, Y. Ma, S. A. Gahan, A. Joly-Amado, S. Spence, X. Yang, K. Nash, S. Y. Yuan
Abstract
BackgroundSevere lung infection can lead to brain dysfunction and neurobehavioral disorders. The mechanisms that regulate the lung-brain axis of inflammatory response to respiratory infection are incompletely understood. This study examined the effects of lung infection causing systemic and neuroinflammation as a potential mechanism contributing to blood-brain barrier (BBB) leakage and behavioral impairment. MethodsPneumonia was induced in adult C57BL/6 mice by intratracheal inoculation of Pseudomonas aeruginosa (PA). Solute extravasation, histology, immunofluorescence, RT-PCR, multiphoton imaging and neurological testing were performed in this study. ResultsLung infection caused alveolar-capillary barrier injury as indicated by leakage of plasma proteins across pulmonary microvessels and histopathological characteristics of pulmonary edema (alveolar wall thickening, microvessel congestion, and neutrophil infiltration). PA also caused significant BBB dysfunction characterized by leakage of different sized molecules across cerebral microvessels and a decreased expression of cell-cell junctions (VE-cadherin, claudin-5) in the brain. BBB leakage peaked at 24 hours and lasted for 7 days post-inoculation. Additionally, mice with lung infection displayed hyperlocomotion and anxiety-like behaviors. To test whether cerebral dysfunction was caused by PA directly or indirectly, we measured bacterial load in multiple organs. While PA loads were detected in the lungs up to 7 days post-inoculation, bacteria were not detected in the brain as evidenced by negative cerebral spinal fluid (CSF) cultures and lack of distribution in different brain regions or isolated cerebral microvessels. However, mice with PA lung infection demonstrated increased mRNA expression in the brain of pro-inflammatory cytokines (IL-1{beta}, IL-6, and TNF-), chemokines (CXCL-1, CXCL-2) and adhesion molecules (VCAM-1 and ICAM-1) along with CD11b+ cell recruitment, corresponding to their increased blood levels of white cells (polymorphonuclear cells) and cytokines. To confirm the direct effect of cytokines on endothelial permeability, we measured cell-cell adhesive barrier resistance and junction morphology in mouse brain microvascular endothelial cell monolayers, where administration of IL-1{beta} induced a significant reduction of barrier function coupled with tight junction (TJ) diffusion and disorganization. Combined treatment with IL-1{beta} and TNF augmented the barrier injury. ConclusionsThese results suggest that lung bacterial infection causes cerebral microvascular leakage and neuroinflammation via a mechanism involving cytokine-induced BBB injury.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neurological Disorder after Severe Pneumonia is Associated with Translocation of Bacteria from Lung to Brain
Qingle Ma, Chenlu Yao, … Chao Wang·bioRxiv·Dec 30, 2022
- Dynamics of Neutrophilia at the Neurovascular Unit Arising from Repeated Pulmonary Inflammation
Wesley Chiang, Herman Li, … Harris A. Gelbard·Journal of NeuroinflammationPeer-reviewed·Mar 25, 2026
- Molecular and functional alterations in the cerebral microvasculature in an optimized mouse model of sepsis-associated cognitive dysfunction.
Paulo Ávila‐Gómez, Yuto Shingai, … Teresa Sánchez·eNeuroPeer-reviewed·Sep 1, 2024
- Neutrophil-chemoattractant CXCL5 induces lung barrier permeability in acute lung injury
Sarah Berger, Cengiz Goekeri, … Geraldine Nouailles·Mucosal ImmunologyPeer-reviewed·Oct 11, 2025
- Pseudomonas aeruginosa induced acute emphysema through bacterial secretion in mice
- Caveolin-1 mediates neuroinflammation and cognitive impairment in SARS-CoV-2 infection
Troy N. Trevino, Avital B. Fogel, … Sarah E. Lutz·bioRxiv·Oct 18, 2023